Pleural Mesothelioma — Comprehensive Guide
Pleural mesothelioma is the most common form of mesothelioma, accounting for approximately 75-80% of all diagnoses. It develops in the pleura — the thin lining surrounding the lungs and chest cavity. Symptoms typically include shortness of breath, ...
About Pleural Mesothelioma
Pleural mesothelioma is the most common form of mesothelioma, accounting for approximately 75-80% of all diagnoses. It develops in the pleura — the thin lining surrounding the lungs and chest cavity. Symptoms typically include shortness of breath, persistent cough, chest pain, fatigue, and unexplained weight loss. Treatment options include surgery (extrapleural pneumonectomy, pleurectomy/decortication), chemotherapy (typically pemetrexed + cisplatin/carboplatin combinations), radiation therapy, and emerging immunotherapy approaches (nivolumab + ipilimumab combination approved 2020). Prognosis varies by stage at diagnosis and cell type — median survival 12-21 months untreated, with multimodal treatment extending survival in selected patients.
Compensation Tracks for Pleural Mesothelioma
Three parallel compensation tracks are typically available: (1) lawsuits against asbestos manufacturers + premise owners, (2) trust fund claims (60+ trusts hold over $30 billion), (3) VA disability for veterans (mesothelioma rated 100%; asbestosis + asbestos lung cancer also covered).
How Whitman Mesothelioma Law Firm Helps
Whitman Mesothelioma Law Firm represents patients diagnosed with Pleural Mesothelioma and their families. Authored by Michelle Whitman, reviewed by Paul Danziger, edited by Rod De Llano.
Medical Disclaimer: This page provides general information about Pleural Mesothelioma and is NOT medical advice. Treatment decisions must be made with your treating physician. For medical guidance, consult a board-certified thoracic oncologist or mesothelioma specialist.